Advanced search
Start date

Sleep medicine platform for universal diagnosis and treatment of sleep disorders

Grant number: 22/01701-1
Support Opportunities:Research Grants - Innovative Research in Small Business - PIPE
Duration: July 01, 2022 - June 30, 2023
Field of knowledge:Health Sciences - Medicine - Medical Clinics
Convênio/Acordo: FINEP - PIPE/PAPPE Grant
Principal Investigator:Tácito Mistrorigo de Almeida
Grantee:Tácito Mistrorigo de Almeida
Host Company:Biologix Sistemas Ltda
CNAE: Desenvolvimento e licenciamento de programas de computador customizáveis
City: São Paulo
Associated researchers:Geraldo Lorenzi Filho


Obstructive Sleep Apnea (OSA) is a disease characterized by recurrent partial or complete obstructions of the upper respiratory airways during sleep, leading to intermittent hypoxia, fragmented sleep, decreased attention and increased cardiovascular risk. OSA is an extremely common disease. In Brazil, 40 million people have some degree of OSA and, worldwide, more than 1 billion. Most of them (85% in the US and 95% in Brazil) remain undiagnosed. Since 2015, Biologix has been a technology-based company dedicated to the development and market introduction of solutions for the diagnosis and monitoring of sleep apnea at home using wearable IoT sensors (wearables), an application for mobile devices and cloud computing. Currently, both technical and commercial results prove to be successful with the business model between companies and customers (B2B2C). However, despite this success, Biologix's interest in popularizing the diagnosis of obstructive sleep apnea is in its early stages, especially in relation to the B2C model. Thus, the objective of this Project is to achieve business development through the incorporation of technological innovations and the B2C model that will make it possible to popularize and democratize the access of the Brazilian population to the diagnosis and treatment of sleep disorders. Thus, the company intends to evolve the current solution, from (i) the development of a new virtual platform for mobile and fixed devices, which incorporates the patient's complete journey; (ii) the development of new sensors/devices; and (iii) the development of artificial intelligence algorithms to assist the professionals in decision making regarding the diagnosis and treatment of sleep apnea. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
Articles published in other media outlets (0 total):
More itemsLess items

Please report errors in scientific publications list using this form.